Organization
Pfizer Inc., Collegeville, PA, United States
8 abstracts
Abstract
ACHIEVEMENT OF 0 OR 1 SWOLLEN JOINTS AND REMISSION IN VERY EARLY (≤4 MONTHS) OR EARLY (4-24 MONTHS) RHEUMATOID ARTHRITIS WITH ETANERCEPT + METHOTREXATE VS. METHOTREXATE ALONE Org: Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, University of Pennsylvania, Phildelphia, PA, Pfizer Inc., Collegeville, PA, United States,
Abstract
ASSESSMENT OF ANALGESIC TREATMENT SWITCH PATTERNS POST-ROFECOXIB WITHDRAWALOrg: Research and Development, NicOx SA, Sophia Antipolis, France, PHARMO Institute, Utrecht University, Netherlands Cancer Institute, Oncology Pain and Inflammation,
Abstract
ASSOCIATION OF PATIENT-REPORTED OSTEOARTHRITIS SEVERITY WITH OTHER PATIENT-REPORTED OUTCOMES IN THE EUROPEAN CLINICAL SETTING Org: Pfizer Inc., Collegeville, PA, United States, Adelphi Real World, Leeds University,
Abstract
AN EVALUATION OF THE PATTERNS OF THERAPY SWITCHING, ADD-ON AND DISCONTINUATION IN PATIENTS WITH OSTEOARTHRITIS (OA) USING THE HEALTH IMPROVEMENT NETWORK (THIN) UNITED KINGDOM DATABASE Org: Avalon Health Solutions, Inc, Pfizer Inc., Collegeville, PA, United States, Leeds Institute of Molecular Medicine,
Abstract
ASSOCIATION BETWEEN BASELINE STATIN TREATMENT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF ORAL SURVEILLANCEOrg: Pfizer Inc., Collegeville, PA, United States, Pfizer Turkey, Pfizer SLU, Brigham and Women’s Hospital and Harvard Medical School,
Abstract
ASSOCIATION BETWEEN NOCTURNAL BACK PAIN AND FATIGUE IN ANKYLOSING SPONDYLITIS AND IMPROVEMENTS IN BOTH PATIENT-REPORTED OUTCOMES WITH ETANERCEPT THERAPY Org: Hamed Medical Corporation, Doha, Qatar, Amgen Inc, Thousand Oaks, CA, Pfizer Inc., Collegeville, PA, United States, Pfizer Inc., New London, CT, United States,
Abstract
BASELINE CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH ANAEMIA IN CLINICAL STUDIES OF TOFACITINIB IN RHEUMATOID ARTHRITISOrg: Pfizer Inc., Collegeville, PA, United States, Pfizer SLU,
Abstract
BIOMARKER CHANGES FOR PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB WITH METHOTREXATE OR GLUCOCORTICOIDS VS TOFACITINIB MONOTHERAPYOrg: Pfizer Inc., Collegeville, PA, United States, Pfizer Japan Inc,